David W. Miles
Mount Vernon Cancer Centre
Northwood, ENG, United Kingdom
Northwood, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data.
Journal: BMJ oncology
Published: March 14, 2025
Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: December 01, 2023
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 27, 2021
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 06, 2021
Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
Journal: Radiology
Published: October 20, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Journal: Health technology assessment (Winchester, England)
Published: September 04, 2020
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 10, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 05, 2020
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Journal: Cancer treatment reviews
Published: December 12, 2019
Protective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' reply.
Journal: Lancet (London, England)
Published: September 09, 2019
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Journal: The Lancet. Oncology
Published: September 03, 2019
Radiocarbon Production Events and their Potential Relationship with the Schwabe Cycle.
Journal: Scientific reports
Published: August 19, 2019
Last Updated: 09/26/2026